Last update: June 11, 2018
Minimal risk for breastfeeding and infant.
S-Enantiomer of Omeprazole with which shares similar characteristics.
Due to a high serum-protein-binding capacity (AEMPS 2012), Omeprazole is excreted into breast milk in non-significant amount (Marshall 1998) without side-effects among breastfed infants from treated mothers (Nava 2006).
Since it's neutralized by the acid pH of stomach, capsules with enteric coated granules are used. Because of this, it is thought that the small quantity of Omeprazole that may reach the breast milk would be neutralized by infant's stomach. In addition, absorption is greatly decreased by the presence of food.
Esomeprazole has been used for treatment of newborn and premature infants (Omari 2009).
Hyperprolactinemia and galactorrhea have been reported by the use of Omeprazole (Pipaliya 2016, Jabbar 2010).
We do not have alternatives for Esomeprazole since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM